|
G7 SYNERGON, the fastest-growing integrated Contract Research Organization (CRO), offers end to end clinical research services to the pharma, biotech and medical device industries. We focus on saving time for the early delivery of the drug to market which is possible by our strong Quality Management System (QMS). We have years of experience and expertise in research as well as a passion for science in providing quality solutions to support projects. We enjoy an enviable reputation since the majority of our work is based on repeat business from our satisfied clients. The key to our success is dedication towards providing quality services to our clients.
Services
Our systems are developed to meet several regulatory norms across the globe. We are staffed with 100 + employees, backed up with strong experience in the areas of project management.
|
|
G7 Synergon’s Clinical Operations team conducts Phases II-IV clinical trials by maintaining the highest standards of ethics, quality and confidentiality. We promote a team approach with emphasis on
|
|
G7 Synergon has an experienced data management team which recognizes the importance of a smooth interface with CRAs, Project Managers, clients and Investigational sites. We ensure that the clinical data
|
|
We provide an extensive range of high quality medical writing services to our clients. Our medical writing team comprises highly qualified personnel mainly from the medical and pharmaceutical
|
|
G7 Synergon provides pharmacovigilance services for product safety for pre- marketing and post-marketing of drugs. We have a dedicated team of trained pharmacovigilance specialists and
|
|
|
At G7 Synergon we understand that safety is of primary concern during all phases of clinical research. Our medical monitors provide medical review and management of clinical trial activities for our clients.All our monitors
|
|
Our statisticians and programmers analyze data for endpoint determination, perform statistical procedures and evaluation criteria, customized programming services and data display formats as per regulatory requirements.
|
|
Bringing a new product from its development to marketing approval is an expensive and lengthy process. If unanticipated delays occur, costs in both time and money can rapidly escalate.The staffs at G7 Synergon are
|
|
The Quality Assurance group at G7 Synergon is one of the key drivers ensuring that the quality of the services match the global standards. Our independent Quality Assurance Unit provides audit
|
|
|
|
|
|